Bain Capital Public Equity Management II, LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 147 filers reported holding TRANSLATE BIO INC in Q1 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management II, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q1 2021$3,916,000
-66.1%
237,503
-62.1%
0.16%
-72.4%
Q4 2020$11,563,000
+257.8%
627,387
+164.2%
0.59%
+177.5%
Q3 2020$3,232,000
-24.1%
237,5030.0%0.21%
-35.1%
Q2 2020$4,256,000
+2.5%
237,503
-43.0%
0.33%
-32.5%
Q1 2020$4,154,000
+22.5%
416,6700.0%0.49%
+51.4%
Q4 2019$3,392,000
-17.8%
416,6700.0%0.32%
-18.1%
Q3 2019$4,129,000
-21.5%
416,6700.0%0.39%
-19.3%
Q2 2019$5,263,000416,6700.49%
Other shareholders
TRANSLATE BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders